Cargando…

Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders

BACKGROUND: In 2014 Parkinson’s UK conducted a research prioritisation exercise with stakeholders highlighting important clinical research questions. The exercise highlighted the need for effective interventions to be developed and tested to tackle a range of non-motor symptoms including: sleep qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogosian, Angeliki, Rixon, Lorna, Hurt, Catherine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315468/
https://www.ncbi.nlm.nih.gov/pubmed/32595982
http://dx.doi.org/10.1186/s40900-020-00212-7
_version_ 1783550257744838656
author Bogosian, Angeliki
Rixon, Lorna
Hurt, Catherine S.
author_facet Bogosian, Angeliki
Rixon, Lorna
Hurt, Catherine S.
author_sort Bogosian, Angeliki
collection PubMed
description BACKGROUND: In 2014 Parkinson’s UK conducted a research prioritisation exercise with stakeholders highlighting important clinical research questions. The exercise highlighted the need for effective interventions to be developed and tested to tackle a range of non-motor symptoms including: sleep quality, stress and anxiety, mild cognitive impairment, dementia and urinary problems. The present work set out to build on this exercise by prioritising types of non-pharmacological interventions to be tested to treat the identified non-motor symptoms. METHODS: A Patient and Public Involvement exercise was used to reach consensus on intervention priorities for the treatment of non-motor symptoms. A Delphi structure was used to support the feedback collected. A first-round prioritisation survey was conducted followed by a panel discussion. Nineteen panellists completed the first-round survey (9 people with Parkinson’s and 10 professionals working in Parkinson’s) and 16 participated in the panel discussion (8 people with Parkinson’s and 8 professionals working in Parkinson’s). A second-round prioritization survey was conducted after the panel discussion with 13 people with Parkinson’s. RESULTS: Physical activity, third wave cognitive therapies and cognitive training were rated as priority interventions for the treatment of a range of non-motor symptoms. There was broad agreement on intervention priorities between health care professionals and people with Parkinson’s. A consensus was reached that research should focus on therapies which could be used to treat several different non-motor symptoms. In the context of increasing digitisation, the need for human interaction as an intervention component was highlighted. CONCLUSION: Bringing together Parkinson’s professionals and people with Parkinson’s resulted in a final treatment priority list which should be both feasible to carry out in routine clinical practice and acceptable to both professionals and people with Parkinson’s. The workshop further specified research priorities in Parkinson’s disease based on the current evidence base, stakeholder preferences, and feasibility. Research should focus on developing and testing non-pharmacological treatments which could be effective across a range of symptoms but specifically focusing on tailored physical activity interventions, cognitive therapies and cognitive training.
format Online
Article
Text
id pubmed-7315468
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73154682020-06-25 Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders Bogosian, Angeliki Rixon, Lorna Hurt, Catherine S. Res Involv Engagem Research Article BACKGROUND: In 2014 Parkinson’s UK conducted a research prioritisation exercise with stakeholders highlighting important clinical research questions. The exercise highlighted the need for effective interventions to be developed and tested to tackle a range of non-motor symptoms including: sleep quality, stress and anxiety, mild cognitive impairment, dementia and urinary problems. The present work set out to build on this exercise by prioritising types of non-pharmacological interventions to be tested to treat the identified non-motor symptoms. METHODS: A Patient and Public Involvement exercise was used to reach consensus on intervention priorities for the treatment of non-motor symptoms. A Delphi structure was used to support the feedback collected. A first-round prioritisation survey was conducted followed by a panel discussion. Nineteen panellists completed the first-round survey (9 people with Parkinson’s and 10 professionals working in Parkinson’s) and 16 participated in the panel discussion (8 people with Parkinson’s and 8 professionals working in Parkinson’s). A second-round prioritization survey was conducted after the panel discussion with 13 people with Parkinson’s. RESULTS: Physical activity, third wave cognitive therapies and cognitive training were rated as priority interventions for the treatment of a range of non-motor symptoms. There was broad agreement on intervention priorities between health care professionals and people with Parkinson’s. A consensus was reached that research should focus on therapies which could be used to treat several different non-motor symptoms. In the context of increasing digitisation, the need for human interaction as an intervention component was highlighted. CONCLUSION: Bringing together Parkinson’s professionals and people with Parkinson’s resulted in a final treatment priority list which should be both feasible to carry out in routine clinical practice and acceptable to both professionals and people with Parkinson’s. The workshop further specified research priorities in Parkinson’s disease based on the current evidence base, stakeholder preferences, and feasibility. Research should focus on developing and testing non-pharmacological treatments which could be effective across a range of symptoms but specifically focusing on tailored physical activity interventions, cognitive therapies and cognitive training. BioMed Central 2020-06-24 /pmc/articles/PMC7315468/ /pubmed/32595982 http://dx.doi.org/10.1186/s40900-020-00212-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bogosian, Angeliki
Rixon, Lorna
Hurt, Catherine S.
Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title_full Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title_fullStr Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title_full_unstemmed Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title_short Prioritising target non-pharmacological interventions for research in Parkinson’s disease: achieving consensus from key stakeholders
title_sort prioritising target non-pharmacological interventions for research in parkinson’s disease: achieving consensus from key stakeholders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315468/
https://www.ncbi.nlm.nih.gov/pubmed/32595982
http://dx.doi.org/10.1186/s40900-020-00212-7
work_keys_str_mv AT bogosianangeliki prioritisingtargetnonpharmacologicalinterventionsforresearchinparkinsonsdiseaseachievingconsensusfromkeystakeholders
AT rixonlorna prioritisingtargetnonpharmacologicalinterventionsforresearchinparkinsonsdiseaseachievingconsensusfromkeystakeholders
AT hurtcatherines prioritisingtargetnonpharmacologicalinterventionsforresearchinparkinsonsdiseaseachievingconsensusfromkeystakeholders